Selected article for: "International license and previous report"
Author: Souvik Maitra; Mansij Biswas; Sulagna Bhattacharjee
Title: Case- fatality rate in COVID- 19 patients: A meta-analysis of publicly accessible database
  • Document date: 2020_4_14
    • ID: 3i2jhvwn_11
    Snippet: We have found a pooled mortality rate of 1.77%, which was less than WHO reported death rate of 3.4% but similar to the first published report of mortality from Wuhan, China. [1] Our pooled estimate of composite poor outcome was around 4%, which was similar to the previous report from China. Another important finding is that presence of a significant heterogeneity and publication biases in the pooled analysis. Underreporting from different . CC-BY.....
    Document: We have found a pooled mortality rate of 1.77%, which was less than WHO reported death rate of 3.4% but similar to the first published report of mortality from Wuhan, China. [1] Our pooled estimate of composite poor outcome was around 4%, which was similar to the previous report from China. Another important finding is that presence of a significant heterogeneity and publication biases in the pooled analysis. Underreporting from different . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • cc NC ND International license and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc NC ND International license and mortality rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • cc NC ND International license and poor outcome: 1, 2
    • cc NC ND International license and previous report: 1, 2, 3, 4, 5
    • cc NC ND International license and significant heterogeneity: 1
    • composite poor outcome and mortality rate: 1, 2, 3
    • composite poor outcome and poor outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • death rate and important finding: 1
    • death rate and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • death rate and mortality rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • death rate and poor outcome: 1, 2, 3, 4, 5, 6, 7
    • important finding and mortality rate: 1, 2
    • International license and mortality rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • International license and poor outcome: 1, 2
    • International license and previous report: 1, 2, 3, 4, 5
    • mortality rate and poor outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • mortality rate and previous report: 1
    • mortality rate and publication significant heterogeneity: 1
    • mortality rate and publication significant heterogeneity bias: 1